Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.77 USD | -6.45% | -9.38% | +42.26% |
05-08 | Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-07 | Piper Sandler Upgrades Design Therapeutics to Overweight From Neutral | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.26% | 228M | |
+48.54% | 56.87B | |
+37.15% | 39.72B | |
-6.02% | 39.27B | |
-6.90% | 28.73B | |
+12.97% | 26.21B | |
-16.91% | 19.79B | |
+31.71% | 12.28B | |
+28.18% | 12.23B | |
+0.38% | 12.12B |
- Stock Market
- Equities
- DSGN Stock
- News Design Therapeutics, Inc.
- RBC Trims Price Target on Design Therapeutics to $29 From $30, Maintains Outperform, Speculative Risk Rating